Danaher Corporation $DHR Shares Sold by Korea Investment CORP

Key Points

• Korea Investment CORP reduced its stake in Danaher Corporation by 7.9% during the first quarter, now owning approximately 0.06% of the company's shares, valued at about $94.55 million.
• Several analysts have adjusted their price targets for Danaher, with the average target now at $247.61 and a consensus rating of "Moderate Buy".
• The company reported earnings of $1.80 per share for the last quarter, exceeding expectations, with a revenue of $5.94 billion, a 3.4% increase year-over-year.

Korea Investment CORP lowered its stake in Danaher Corporation (NYSE:DHR - Free Report) by 7.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 461,229 shares of the conglomerate's stock after selling 39,521 shares during the quarter. Korea Investment CORP owned about 0.06% of Danaher worth $94,552,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. GHP Investment Advisors Inc. lifted its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the period. Heck Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter worth about $27,000. Sierra Ocean LLC raised its position in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in Danaher in the first quarter worth about $31,000. Finally, Dunhill Financial LLC raised its position in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after acquiring an additional 67 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on DHR shares. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Robert W. Baird boosted their price target on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Guggenheim reiterated a "buy" rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. UBS Group dropped their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Finally, JPMorgan Chase & Co. dropped their price target on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 22nd. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Price Performance

Shares of DHR opened at $210.84 on Monday. The company has a market capitalization of $150.97 billion, a price-to-earnings ratio of 44.86, a P/E/G ratio of 2.94 and a beta of 0.73. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The business's 50-day moving average is $199.94 and its 200-day moving average is $199.54.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The firm's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.72 EPS. Equities research analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.